Get 250+ investors tailored to your startup

Invest in your industry and stage
Emails & contact info included
Excel and CSV export
Automatically

Trusted by 3,000+ startups

Top 50 Life Science Startup Investors in Spain in May 2025

Last updated: May 2025 A list of 50 angel investors and VC (Venture Capital) funds that invest in Life science startups based in Spain. We rank investors based on the number of investments they made in Life science companies from Spain. We update this investor list every month.

Top 50 Life Science Startup Investors in Spain in May 2025

Investor	Life Science Spain investments
Centre for the Development of Industrial Technology (CDTI)	8
Bullnet Capital	7
Capital Cell	6
ENISA	4
Asabys Partners	4
Invivo Capital Partners	3
Criteria Venture Tech	2
Demium Capital	2
Inveready	2
Ysios Capital	2
Talis Capital	2
Josep Carreras Leukaemia Research Institute	2
BStartup	2
Speedinvest	2
BoxOne Ventures	2
Alta Life Sciences	2
Xesgalicia	2
Monte Carlo Capital	2
Amino Collective	2
Charme Capital Partners	2
Amadeus Capital Partners	2
Kurma Partners	1
Clave Mayor	1
Green Generation Fund	1
Global health sciences venture fund	1
Catalan Institution for Research and Advanced Studies	1
Mariliis Holm	1
Grow Venture Partners	1
European Investment Bank	1
UCB Ventures	1
Innova-Tech Consulting	1
Santander	1
Arman Anatürk	1
BCN PEPTIDES	1
New Enterprise Associates	1
Milad Alucozai	1
Nara Capital	1
Fides Capital	1
Ezten Venture Capital Fund	1
INNVIERTE ECONOMIA SOSTENIBLE SICC SME SA	1
Novartis Venture Fund	1
Reig Jofre	1
John Bethell	1
Inaki Berenguer	1
Alma Mundi Ventures	1
David Brandes	1
Stemar Capital	1
Addition	1
GENESIS Biomed	1
Sofinnova Partners	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

The Center for Industrial Technological Development (CDTI) is a public corporation under the Ministry of Economy and Competitiveness, which promotes innovation and technological development of Spanish companies. Is the entity which channels requests for funding and support to projects I + D + i of Spanish companies in the national andinternational levels. The CDTI has a staff of more than 300 people formed three quarters of engineers and graduates. Although the bulk of the infrastructure of the CDTI is located in Madrid, the Centre offers Spanish companies a strategic network of offices and representatives abroad (Japan -SBTO (Spain Business and Technology Office) - Belgium -SOST (Spain Office of Science and Technology) and Permanent Secretariat Eureka-, Brazil -FINEP (Financier of Studies and Projects) -, Korea, Chile, Morocco, China, India, Mexico and USA) to support them in their technological activities of type int .

Investment focus

Biotechnology, Health Care, Software
Funding Round, Seed, Grant
Spain, United States, France

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Basquevolt — Basquevolt is a leader in solid state battery technology.
Pangea Aerospace — SPONSORSHIP PROPOSAL SPONSORSHIP PROPOSAL MISSION In a very conservative sector, European space engineers and business experts have gathered to unlock the untapped potential of new technologies that will drastically reduce the cost of launch

Independent Venture Capital Firm specialized in high technology Spanish start-ups. Helping tech entrepreneurs during the early stages of their company to build successful businesses

Investment focus

Software, Information Technology, Enterprise Software
Funding Round, Seed, Series A
Spain, United States, Mexico

Portfolio highlights

MLCode — Accelerated by massive AI/ML adoption, Data is to become the most critical resource for Enterprises. MLCode vision is to protect that Data. MLCode: Data Security Automation.
wooptix — Wooptix is a developer of light field and wavefront phase imaging platform designed to acquire all information about the light using...
Inspiration-Q — Inspiration-Q focuses on developing and commercializing software solutions inspired by quantum computing for financial applications.

Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.

Investment focus

Health Care, Biotechnology, Medical
Equity Crowdfunding, Funding Round, Seed
Spain, United States, United Kingdom

Portfolio highlights

Exheus — Exheus tells everything that you need to know to take maximum care of yourself and avoid risks to your health, exheus is much more than a DNA test that only indicates which genes you have.
MediQuo — MediQuo is a hospital in your pocket, connecting patients and professionals for any health interaction. Healthcare today has 75% of unnecessary medical visits that could be taken in the distance, and the vast majority of health professionals are using messaging platforms such as WhatsApp to communicate with patients or other health professionals.MediQuo is a chat-based app specialised in health, GDPR and health data compliant, giving professionals time control, incorporating patient medical history and phone privacy. Allowing also video and audio communication. It is a place for discussion, appointments or medical consultation with your doctor or any new health professional. Also includes immediate 24/7 medical response and a network, for health information and professional discovery. We have done already 1M consultations and got 600k app downloads. Our Google Play Ratings are 4,6 (with 6k reviews). We are amongst the top health apps in Spain and Latam.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

ENISA is a public company under the Ministry of Industry, Energy and Tourism, through the Directorate General of Industry and Small and medium-sized enterprises which, since 1982, actively participates in the financing of viable and innovative business projects.

Investment focus

Software, Health Care, E-Commerce
Seed, Debt Financing, Pre-Seed
Spain, United States, France

Portfolio highlights

Mygocu — Mygocu is a platform for selling, organizing, and managing excursions and large-scale events.
Supercubo — Supercubo is a Spanish startup based in Seville, founded with the goal of promoting healthy lifestyle habits by facilitating the creation of outdoor functional training centers through a scalable, low-risk, and cost-effective solution.Our project aims to both ease access for entrepreneurs and foster the growth of our community.The company wasfounded in December 2023 (starting operations in March 2024), and to date, the proof-of-concept for our three business lines has already been implemented and validated: • Own gyms • Franchisees • Third-party sales
Modular DS — Modular DS enables WordPress professionals and businesses to save time managing their websites.

Asabys Partners is a venture capital firm that invests across the board in human healthcare. The company is active in the health-tech and biopharma industries and aims to invest in Spain and abroad in innovative and transformative technologies. Asabys Partners are motivated by the idea of pushing the boundaries of science and medicine. This is donethrough the sourcing and financing of the most disruptive technologies, and through the collaboration with the best internal and external talents of our industry.

Investment focus

Biotechnology, Medical Device, Health Care
Series A, Seed, Series B
Spain, France, Belgium

Portfolio highlights

Quibim — Leading radiomics company pioneering quantitative imaging biomarkers and medical applications in precision medicine.
DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
INBRAIN Neuroelectronics — We are scientists, doctors, techies and humanity lovers, with the mission of building neuroelectronic interfaces to cure brain disorders.

Invivo Capital is a team of knowledgeable professionals with the scientific, technical, and financial know-how required to analyze and make investments that provide value to the invested company. They also have a network of contacts and key strategic relationships in the health ecosystem.

Investment focus

Biotechnology, Health Care, Life Science
Seed, Funding Round, Series A
Spain, France, Belgium

Portfolio highlights

Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.
Neumirna Therapeutics — Founded in 2020, NEUmiRNA focuses on achieving transformative disease modification for neurological conditions.

Criteria Venture Tech is the tech VC fund of CriteriaCaixa which invests in B2B SaaS and DeepTech companies in early and growth stages (Pre-Seed to Series C) managing more than €300M of AUM.

Investment focus

Software, Biotechnology, E-Commerce
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Medlumics — Medlumics is a medical device start-up born in 2009 from a compromise with improving human living standards by means of technology.
KIT-AR — Reduce time and costs spent fixing errors on your manufacturing shopfloor with quality assurance and augmented reality- Click in to find how!
iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.

Demium is a talent investment company founded in Spain in 2013 with the aim of supporting the best professionals and helping them to carry out successful projects, always with an eminently digital and technological component. In November 2020, it's asset management company, Demium Capital, started operating with a first €50M fund to invest inmore than 75 early-stage startups per year (pre-seed/seed), becoming the most active venture capital fund in Spain. Startups such as Hannun, Voicemod, Swipcar, Citibox, Singularu or Landbot, among others have been created in the incubator. The company is present in five countries: Spain, Portugal, Poland, Ukraine and Czech Republic

Investment focus

Software, Information Technology, Artificial Intelligence
Pre-Seed, Seed, Series A
Spain, Portugal, Poland

Portfolio highlights

Dealcar — DEALCAR is a company that digitalizes the used car market through a SaaS platform, enabling fully digital transactions. This platform creates a network effect benefiting dealers, partners, and customers. • Dealers: Increase revenue by selling extra products and boost sales by reducing turnover time. • Partners: Distribute products at the pointof sale without marketing expenses, lowering operational costs. • Consumers: Purchase a used car easily in just three steps, enjoying a smooth, trusted process similar to renting but with the benefits of owning a car.
KomboAI — Increase your sales conversion rate and close more deals with KomboAI Find the right leads, engage them with purpose and improve your skills every day. 7-Days Free Trial See Kombo in Action No credit card required Over 600+ sales reps are already using KomboAI during their job Join the sales revolution today Find the right
Aino — Ai-powered platform to create, design, and publish interactive maps for your spatial data projects.

Inveready is a leading Spanish financial services firm focused on investment solutions and wealth management.

Investment focus

Software, Biotechnology, Health Care
Seed, Funding Round, Series A
Spain, United States, United Kingdom

Portfolio highlights

Geniova — Geniova is a Spanish start-up that specializes in invisible orthodontics. The company’s patented method combines the power of a lingual nickel titanium arch and conventional aligners to obtain the fastest and most predictable technique in teeth alignment. Geniova’s innovative approach to orthodontics has earned it recognition as one of the mostinnovative start-ups globally in 2021. With remarkable international potential, Geniova is poised to revolutionize the field of orthodontics.”
Intelex Vision — INNOVATION AT THE CORE We embrace the latest open-source AI/ML science developed by Google, Facebook and Microsoft. Our solution is a unique blend of in-house technology and flexible system architecture, that is easy to maintain and engineered to expand and solve new problems. This allows us to integrate state-of-the-art
The Channel Store — The Channel Store is a company specializing in the creation, distribution, and monetization of various types of channels, particularly in the FAST (Free Ad-Supported Streaming TV) and AVOD (Ad-Supported Video on Demand) sectors. It operates as a B2B service provider that manages content negotiations, integration, and monetization for its partners,enabling broadcasters, content owners, telcos, and streaming services to access and distribute a wide range of live and on-demand content globally.

Leading #lifesciences #venturecapital firm financing highly #innovative #biotechnology companies #worlwide.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
Spain, United States, Switzerland

Portfolio highlights

ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
Memo Therapeutics — Memo Therapeutics AG translate immune responses into superior medicines. Our best-in-class antibodies transform lives of patients with viral infections & cancer
Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.

We back founders who see the future differently.

Investment focus

Software, Information Technology, E-Commerce
Series A, Seed, Series B
United Kingdom, United States, Germany

Portfolio highlights

Acin — Acin delivers at speed by combining unique industry data, AI and high touch expertise. The trusted partner, built by the industry, for the industry
Laced — Discover the latest sneaker releases with Laced. The UK and Europe's authentic sneaker marketplace, discover coveted styles from Nike, Air Jordan, Yeezy, New Balance and more. Buy and sell now with Laced.
Rubi Laboratories — Rubi Laboratories turns carbon emissions into carbon-negative textiles for the fashion industry, with a proprietary synthetic biology technology.

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Investment focus

Life Science, Biotechnology
Seed
Spain

Portfolio highlights

OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

A Banc Sabadell initiative to support young companies in developing their projects. Bstartup is designed to support entrepreneurs so their projects can be developed with maximum guarantees of success. - Investment and growth - Specialized products and branches - Collaborative innovation

Investment focus

Software, Information Technology, Artificial Intelligence
Seed, Funding Round, Pre-Seed
Spain, Mexico, United States

Portfolio highlights

Kloutit — Gestiona los chargebacks potenciando las defensas con IA
Dost — Dost automates the process of incoming supplier invoices to help CFOs and Finance Managers of mid-size and large companies with a high volume of invoices to improve efficiency, accuracy in data entry and reduce time when processing incoming invoices by leveraging artificial intelligence (AI) and intelligent process automation (IPA).
xNova International — Find US importers with the xNova International platform in seconds. Monitor your competitors, analyze your product's demand in the US, and much more.

Speedinvest is one of Europe’s most active early-stage investors, with more than €1bn AUM, 40 investors, and offices in Berlin, London, Munich, Paris, Vienna and San Francisco. Your success is our priority, so we don’t just send some money and "check in" at board meetings. Our mission is to empower you with game-changing support throughevery stage of your journey. Our focused investment teams know your industry inside and out. Their Deep Tech, Fintech, Industrial Tech, Network Effects, Digital Health and Subscriptions experience, know-how and deep networks are yours from day one. You also have full access to our in-house Platform+ team of operational experts who can provide tailored growth marketing, people (HR), US business development, and networking support throughout every stage of your journey.

Investment focus

Software, FinTech, Financial Services
Seed, Series A, Pre-Seed
United Kingdom, Germany, Austria

Portfolio highlights

trawa — The partner for renewable and affordable electricity for businesses. Get electricity directly from solar and windparks with corporate PPAs.
remberg — The remberg software helps industrial companies become digital champions in customer & field service for their machines and equipment, moving from reactive and analog to proactive and digital, thereby eliminating paper chaos and preparing them for the age of the Internet of Things (IoT).
Riverse — The impact monetization platform enabling European green-techs finance their growth by valorizing their impact

BoxOne Ventures is a privately held investment firm that focuses on early-stage companies across the most impactful, interesting and fast-changing sectors.

Investment focus

Biotechnology, Health Care, Software
Seed, Pre-Seed, Series A
Canada, United States, Spain

Portfolio highlights

Dispersa — Harnessing the power of microbe-derived natural solutions to decarbonize the chemicals industry.
Stately Bio — Stately Bio is the trade-off between measuring cells and keeping them alive. Our patented ML technology measures cell identity, behavior, and maturation—all directly from live-cell, label-free imaging.
Axonis Therapeutics — AXONIS Therapeutics, Inc. is advancing breakthrough discoveries to develop first-in-class therapies for neurological disorders.

Alta Life Sciences is a leading multistage venture capital investment firm. Alta LS will invest in companies at all stages of development: from seed financing through commercial growth. Alta LS invests in all areas of life sciences including biotechnology, medical devices, diagnostics, genomics and digital health.

Investment focus

Biotechnology, Health Care, Medical Device
Series A, Funding Round, Seed
Spain, United States

Portfolio highlights

DeepUll — DeepUll is a biotech company that focuses its activity on the development of a new diagnostic system for early-stage sepsis condition. DeepUll’s proposal is based on quickly identifying the pathogens and offering the antibiogram within a few hours on the one hand, and on using the data and learning about the patient’s immunological and functionalstatus on the other. The system allows doctors to predict the future appearance and evolution of sepsis within a short period of time and thus provide a suitable clinical response even before the symptoms arise.
Peptomyc — Peptomyc is a company focused on the development of a new generation of cell-penetrating peptides (CPPs) targeting the Myc oncoprotein for cancer treatment. The company was founded in December 2014 and it is based on Dr. Soucek’s scientific research in Omomyc (the best direct Myc inhibitor known to date) over the last twenty years.Currently,cancer incidence in the world exceeds 14 million cases per year and results in 8 million deaths annually. Moreover, such numbers are forecast to rise by 75% over the next 20 years (World Cancer Report. International Agency for Research on Cancer 2014). At the moment, standard therapies include surgery, radiotherapy, chemotherapy, and, in a restricted subset of cancers, precision medicine. Unfortunately, very often these therapies fail, due to the development of resistance.Peptomyc has adopted a different strategy based on the inhibition of the oncoprotein Myc, which is found deregulated in the majority of human cancers. Myc holds a non-redundant function in cancer around which tumors cannot evolve, hence targeting Myc is the most promising therapeutic opportunity to date. Although Myc plays a central role in cancer there is currently no Myc inhibitor in the market.
Mediktor — Mediktor is an interactive tool that can analyse users' symptoms and evaluate their state of health. It also allows them to chat with a doctor in real time.

XesGalicia is a Galician Venture Capital Management firm. It finances company development through the temporary acquisition of minority shares of the capital of unquoted companies.

Investment focus

Software, Biotechnology, Pharmaceutical
Seed, Funding Round, Pre-Seed
Spain, Portugal

Portfolio highlights

Envita — Envita is a social innovation start-up for the development of innovative digital solutions for organizations.
Appentra — Ensure correctness, modernization, security, and optimization for your Fortran, C, and C++ code with a powerful and efficient solution.
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.

Monte Carlo Capital was founded in 2009 by former investment banker Ian Sosso, winner of the 2019 “Best European Early Stage Investor” award from EBAN, the Brussels-based European trade association for business angels representing the 30,000 European angel community with a presence in 50 countries. Monte Carlo Capital combines the best featuresof business angels and venture capital. We invest via fund and via SPVs. We have been the Lead in many of our investments and are increasing our Co-Investments with some of the world’s leading VCs. Typical investments start at pre-seed/seed and we regularly follow on to Series A & Series B rounds. Monte Carlo Capital invests across sectors, including Saas, Fintech, DeepTech and Health Care, in the US, Europe and the UK.Our solo managing partner was a former investment banker, spending most of his career in Asia and the UK. He retired about 15 years ago, and set up his own angel group. After being quite successful, he decided to launch the fund (January this year).

Investment focus

Medical Device, Financial Services, Medical
Seed, Funding Round, Series A
United States, United Kingdom, Spain

Portfolio highlights

Chaiz — Chaiz is the first digital marketplace for extended car warranties. Search, compare and buy service plans from top providers completely online.
Scout AI — Scout AI is building the robotic foundation model for defense.
CorFlow Therapeutics — CorFlow Therapeutics is a medtech startup that develops proprietary technologies for diagnosis and treatment of microvascular obstructions in heart attack patients. The CorFlow technologies enable interventional cardiologists to diagnose and treat MVO in severe heart attack patients thereby potentially reducing the short- and long-term complicationrates in these patients.

Amino Collective is an institutional venture capital firm investing at seed stage in health and bio companies. They help bring life-changing ideas to life by backing, connecting, and advancing our collective of entrepreneurs and scientists. The firm intends to invest in the sectors of biology, biotech, health tech, science, digital health, lifescience, and synthetic biology.

Investment focus

Health Care, Biotechnology, Medical
Seed, Pre-Seed, Series A
United States, Germany, United Kingdom

Portfolio highlights

Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
Inductive Bio — Bringing the data, ML, software, and expertise needed to rapidly solve your most challenging ADMET problems.
Tandem Health — Focus on providing care, while Tandem helps you easily write medical notes directly after the patient consultation.

Charme Capital Partners is a European mid-market private equity fund, supporting management teams and shareholders to achieve transformational change, growth and internationalisationFrom our offices in Milan, London and Madrid we invest in businesses across Europe with an enterprise value of €100m to €500mContinuous interaction with ourinvestor base is key in sourcing new opportunities, testing investment theses and growing portfolio companies

Investment focus

Genetics, Life Science, Biotechnology
Series A
Spain

Portfolio highlights

Bianalisi — Bianalisi provides services that include toxicological examination of the hair, diagnostic imaging, specialised examinations, laboratory analysis, physiotherapy and rehabilitation, occupational medicine, and more. They offer diagnostic services.
Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.

Amadeus Capital Partners, Venture Capital For Technology Companies. We Back Entreprenuers To Win. Contact Our Experienced Team Of Investors Today

Investment focus

Software, Artificial Intelligence, Machine Learning
Series B, Seed, Series A
United Kingdom, United States, Spain

Portfolio highlights

Inephany — Inephany is a company focusing on improving the efficiency of AI, particularly neural networks and Large Language Models (LLMs).
Safe Intelligence — Safe Intelligence specializes in deep validation AI systems, focusing on enhancing the reliability of artificial intelligence models.
iPronics — Discover the power of lossless optical switches for low latency and flexible AI architectures. Increase density and reduce power consumption with our innovative technology.

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Investment focus

Health Care, Biotechnology, Pharmaceutical
Series A, Seed, Series B
France, Switzerland, Spain

Portfolio highlights

Coave Therapeutics — Coave Therapeutics is active in the field of gene therapies in rare ocular and CNS (Central Nervous System) diseases.
Hopia — Hopia is a scheduling solution that optimizes human and material resources for healthcare institutions. Hopia centralizes the management of doctors' and nurses' schedules and uses constrained optimization and prediction algorithms to propose the most optimal organization for all stakeholders.
Germitec SAS — Germitec is a world leader in UV-C high-level disinfection. Fast, safe, chemical-free, one-button UV-C high-level disinfection for ultrasound probes.

Clave Mayor is a management company of closed investment entities based in Navarra.

Investment focus

Biotechnology, Software, Medical
Funding Round, Seed, Series A
Spain, Germany, United States

Portfolio highlights

MOA — MOA make healthy food for a sustainable world that solves growing global food demands. They are establishing a new industry of sustainable food that solves growing global food demands without the need for arable land. They are focused on designing high-value, natural and nutritious food.
Innitius — Diagnostic of preterm birth risk and induction labor success probabilities through the use of torsional ultrasound technology
Ojer Pharma — Ojer Pharma engages in the research, development, production, and marketing of dermopharmaceutical products in Spain. It develops prescription medicines, cosmetics, and medical devices. The company has developed a vehiculization technology in the form of bioadhesive transparent gels, which acts as a sustained-release matrix of dermatologicalactives, such as lipophilics and hydrophilics.

The Green Generation Fund invests in early stage Food Tech and Green Tech companies that make our lives and diets more sustainable, healthy and ethical.

Investment focus

Food and Beverage, Biotechnology, Food Processing
Seed, Series A, Pre-Seed
Germany, United States, United Kingdom

Portfolio highlights

Klim — Klim enables farmers to transition to regenerative agriculture at scale by providing them financial support, knowledge, documentation tools, and a community via our digital companion for farmers.Klim-verified carbon removal credits, generated by Klim farmers, help companies to transition to net zero by offsetting their carbon emissions locallyand with maximum impact and transparency.
FluoRok — By employing our patented technology, we can produce fluorochemicals without the production of toxic and highly dangerous hydrofluoric acid
Reverion — Reverion offers electrical efficiencies for both power generation and energy storage. Reverion was foun ded in 2022 and was headquartered in Bayern, Germany.

The strength of the life science industry here and the quality of its technologies. We anticipate that internationally competitive Canadian companies will do well having a fund of this size and calibre at their doorstep, and we believe such a fund will energize the sector and be a magnet for further capital."

Investment focus

Biotechnology, Health Care, Therapeutics
Series C, Series A, Series B
United States, Canada, Spain

Portfolio highlights

EyeYon — EyeYon Medical is an Israeli start-up company that develops innovative medical devices for the treatment of corneal edema.EyeYon Medical was founded by Dr. Daphna Ofer, a senior ophthalmologist, Dr. Arie Marcovich, a senior cornea surgeon, and Nahum Ferera, an experienced business executive. The company operates within the Van Leer TechnologyIncubator.
Variantyx — Based on clinical whole genome sequencing (WGS) and using a single patient sample, Variantyx's Genomic Unity® test identifies and reports all major variant types including small sequence changes, structural variants, mitochondrial variants and short tandem repeat expansions. This comprehensive test test eliminates the need for traditionalstep-wise, reiterative genetic testing.
CalciMedica — CalciMedica was founded in December 2006 by Gonul Velicelebi, Ph.D., Kenneth Stauderman, Ph.D. and Jack Roos, Ph.D., all previously with TorreyPines Therapeutics, where they discovered the role of STIM1 in the Icrac pathway in 2003. Other co-founders, all from the CBR Institute, include Anjana Rao, Ph.D., Patrick Hogan, Ph.D. and Stefan Feske, M.D,who identified Orai1 as the CRAC channel subunit in 2006.

ICREA is a foundation supported by the Catalan Government for the advancement of research.

Investment focus

Life Science, Biotechnology
Seed
Spain

Portfolio highlights

OneChain Immunotherapeutics — CAR-T Immunotherapies against hematological malignancies

I am a food scientist, entrepreneur and investor. Through SFV (sustainablefoodventures.com), I back founders building the future of cell-based, plant-based and recombinant food.

Investment focus

Food Processing, Seafood, Wellness
Pre-Seed, Angel
Spain, Iceland, United States

Portfolio highlights

Loki Foods — We're producing sustainable, plant-based foods from the Arctic. Iceland’s first plant-based cod and seafood!
Sobo Foods — Sobo Foods is a plant based comfort food provider.
Libre Foods — MEAT, BUT MAKE IT MUSHROOMS. GET READY TO TASTE THE POWER OF FUNGI

Venture Capital for Entrepreneurs with seasoned experts and advisors to succed in creating value in a meaningful way. Coaching and Mentoring Ideas People

Investment focus

Health Care, Artificial Intelligence, Biotechnology
Pre-Seed, Funding Round, Seed
Spain

Portfolio highlights

Tirecat — Tirecat specialized in developing sophisticated tissue regeneration treatments to combat chronic and terminal diseases.
Kreios Space — Kreios Space is developing an electric propulsion system to revolutionize the satellite industry. With this technology we enable orbital keeping in VLEO (Very Low Earth Orbits) thanks to renewable energy. We make space applications easier.
The Blue Box Biomedical Solutions — Pain-free, low-cost, sensitive, radiation-free device to detect breast cancer in urine

The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.

Investment focus

Biotechnology, Health Care, Energy
Debt Financing, Post-IPO Debt, Funding Round
France, Germany, The Netherlands

Portfolio highlights

UP Catalyst — UP Catalyst produces sustainable carbon nanomaterials and graphite for the green energy storage industry.
Sidekick Health — Our mission is to develop and deliver effective personalized digital therapeutics that prevent suffering and add millions of quality life years to people around the world. Our multi-chronic digital care platform allows us to scale the production of clinical treatments across major chronic diseases.
Heura Foods — Heura is a plant based startup founded by food activists Marc Coloma and Bernat Añaños in April 2017. Its mission is to create solutions that will leave the current food system obsolete and accelerate the transition to a world where animals are out of the equation. Their Mediterranean culinary heritage is reflected on their products: clean label,high nutritional values and taste.

UCB Ventures is a €150 million strategic corporate venture fund

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Seed
United States, Belgium, Spain

Portfolio highlights

ViaNautis — Precision Solutions
Neurona Therapeutics — Neurona Therapeutics is a pre-clinical stage biotechnology company that was founded by four neuroscientists and stem cell pioneers at The University of California, San Francisco. They are focused on the discovery and development of cell-based therapies to treat intractable neurological disease. Its initial aim is to generate therapeuticcompositions of a specific type of nerve cell (or neuron) for targeted delivery into the injured nervous system. Based on nearly two decades of research, they believe that particular subpopulations of neurons have the unique ability to integrate and repair dysregulated neural circuits. Its talented team of scientists, scientific advisors, and board directors is working to accelerate breakthrough treatments for patients with significant unmet medical needs.
Switch Therapeutics — Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi).

Innova-Tech Consulting provides independent specialist Audio Visual and Technology consulting services.

Investment focus

Solar, Energy, Medical
Series A, Seed, Series B
Canada, Spain

Portfolio highlights

SiXtron Advanced Materials — Founded in 2004, SiXtron is a private, venture backed company located in Montreal, Quebec, focusing on developing anti-reflective coating solutions for the solar cell industry.Other highly scalable and cost-effective thin film coating solutions, for both the electronics industry and the industrial coatings sector, are under development. Sixtronthin films have unique optical and mechanical properties, and can be deposited without the complex requirements of hazardous silane gas.
Libera Bio — Libera Bio is a biopharmaceutical company devoted to the development of a new class of therapeutics to address unmet medical needs in cancer
Optosecurity — PAX CHECKPOINT combines automated screening lanes with a screening software to create a fully integrated checkpoint solution.

Our purpose is to help people and businesses prosper. We strive to make all we do Simple, Personal and Fair.

Investment focus

Energy, Financial Services, Renewable Energy
Debt Financing, Post-IPO Debt, Seed
Spain, United Kingdom, United States

Portfolio highlights

Karbon Homes — Karbon Homes is involved in construction, property development and management with an emphasis on quality, service and sustainability.
Recurrent Energy — As a leading provider of distributed solar power, Recurrent Energy is overcoming the barriers to widespread solar adoption, making renewable energy a practical choice for today's large scale energy users. They are a developer and owner of locally-sited solar power systems, selling clean electricity to their customers worldwide at competitiverates via a Power Purchase Agreement (PPA) or Feed-in Tariffs (FiT). In return, their utility, commercial, and government customers achieve energy independence, predictable pricing, and enhanced sustainability.
Cypress Creek Renewables — Cypress Creek Renewables is committed to making the world cleaner and healthier. From development to operation, we create and operate valuable solar and storage projects that benefit communities for decades.

Arman Anatürk is Co-Founder @ FoodHack.

Investment focus

Biotechnology, Food and Beverage, Wellness
Seed, Pre-Seed
Spain, Israel, Germany

Portfolio highlights

Bosque Foods — Kinoko Labs develops the next generation of meat substitutes, starting with whole-cut meat items made from fungal mycelium produced organically. Headquartered in New York.
Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.
Kynda — Keen 4 Greens offers a wide range of vegan products. Founded in 2019, Keen 4 Greens is based in Hamburg, Germany.

BCNPeptides is dedicated to pioneering R&D in cutting-edge bioactive peptides. We deliver tailor-made, high-quality solutions

Investment focus

Medical, Biopharma, Life Science
Funding Round
Spain

Portfolio highlights

Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

Investment focus

Software, Health Care, Biotechnology
Series B, Series A, Series C
United States, India, China

Portfolio highlights

Embrace — Stay informed with Embrace's mobile monitoring solutions. Optimize app performance & user experience with our comprehensive platform. Learn more now.
Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
Functional Finance — Automated FinOps for Insurance. Unify and automate all of your financial operations, workflows and servicing without replacing your current infrastructure.

Dr. Milad Alucozai specializes in translating scientific and technological breakthroughs into scalable commercial ventures. As an Afghan-American neuroscientist, entrepreneur, and global investor, he leverages his expertise in bioengineering, computational biology, and machine learning to identify promising innovations and develop strategies fortheir successful market entry and growth. He focuses on accelerating the process of bringing groundbreaking discoveries from the lab to market, particularly in the life sciences and computationally-driven fields.Dr. Alucozai is a co-founder of Revalia Bio, which aims to create a human-centric infrastructure for drug discovery and development. By utilizing non-transplantable human organs donated for research, Revalia provides the scientific community unparalleled insights into patient biology, ultimately aiding in the development of better treatments and cures. In 2024, he partnered with The Wyss Institute at Harvard University to launch and co-host the popular "Code to Cure" series, exploring the convergence of AI, biology, and healthcare. He also contributes his expertise as a Senior Fellow in Healthcare Engineering at the Regenstrief Center.His background includes leading 70 early-stage investments as Head of Bio and Deep Tech at BoxOne Ventures, establishing the firm as a key player in North America's VC landscape. He also served as a Venture Partner at Entrepreneur First, a globally recognized talent investor backed by notable figures like Patrick and John Collison of Stripe and Reid Hoffman of LinkedIn, with a portfolio exceeding $10 billion in value. He mentors entrepreneurs across North America and Europe through channels like the Creative Destruction Lab.Throughout his operating and investing career, he has been instrumental in helping founders secure hundreds of millions in capital and facilitating over $1 billion in startup-pharma partnerships. Often serving as the first investor, he guides companies from concept to successful exit and shapes business development for high-growth, venture-backed startups. His advisory work also extends to established corporations; at Accenture, he led teams advising top pharmaceutical companies on their R&D, innovation, and business development strategies. In 2020, he formally served as an External Advisor to AstraZeneca.He was a National Science Foundation Scholar and Macklin Fellow at Johns Hopkins Medicine. He graduated Phi Beta Kappa with a Neuroscience degree from Purdue University’s Honors Program, earned a master’s in Immunology and Public Health as a George J. Mitchell Scholar, and holds a doctorate from the Richard M. Fairbanks School of Public Health. Additionally, he completed a visiting scholarship at the Wyss Institute at Harvard University.

Investment focus

Biotechnology, Health Care, Medical
Seed, Series A, Pre-Seed
United States, Canada, United Kingdom

Portfolio highlights

Arpeggio Bio — We engineer medicine based not on a single target, but the biological network as a whole.
Future Fields — Future Fields Cellular Agriculture: Serum-Free Growth Media Supplements and Recombinant Proteins - Optimized for the Future of Food.
Eigen Therapeutics — Eigen Therapeutics is a biotechnology company developing combination therapeutics for cancer. The company is in the research and development of synergistic therapies that improve efficacy while reducing the toxicity of small molecule therapies and immunotherapies, enabling physicians to get access to novel drugs in areas of unmet medical needs.

As asset managers, we invest on behalf of third parties. Our fear of losing their money is greater than the fear of losing an opportunity. Our investment style consists of value orientation, specialization and trust, applying our investment criteria in a disciplined way. We invest to transform the companies into industry leaders. With a hands-onapproach, Nara invests in assets enhancing its value with a long-term view. We are a highly experienced team with the patience and tenacity required to see deals through, committing our own money. We create value in a sustainable way, investing in a responsible way to generate a positive impact on the community. We analyze each investment in detail in order to create shared value for our investors, partners, customers, suppliers and workers.

Investment focus

Biotechnology, Life Science, Medical
Seed, Funding Round
Spain

Portfolio highlights

Heecap — Heecap is a non-invasive, tailored electrostimulation technology that maintains respiratory muscle strength in these patients.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Gyala Therapeutics — Gyala Therapeutics is focused on developing new CAR-T therapies for treating hematological malignancies. CAR-T (chimeric antigen receptor T cells) is a type of gene therapy in which T lymphocytes -a type of white blood cells that play a key role in immune responses- are extracted from the patient and modified to attack tumour cells. T lymphocytesare obtained through apheresis (a technique that allows separation of blood components) and genetically reprogrammed with a receptor that binds to a tumor factor. When these cells are transduced back to the patient, they are to specifically recognize tumour cells and attack them. Several types of CAR-T cells have demonstrated efficacy in the treatment of leukemias and B cell lymphomas.

Fides Capital is an investment firm, specialized in seed and early stage technology-based companies with scalable B2B business models that have already achieved recurring income. We back committed and experienced teams who are capable of leading ambitious projects with international projection. But, beyond the professional abilities, for usit's essential to have a personal understanding and alignment of interests with the entrepeneurs in order to row together in the same direction. Partnering with the teams is a key pillar in Fides's investment strategy since we like to collaborate actively with them, sharing our experience and knowledge. We invest between 50,000 € and 400,000 € per deal by disbursing funds in gradual installments and we co-invest with other participants that assume the role of lead investor.Our portfolio companies are mainly in the telecom, B2B services, health, fintech and edutech sectors: - AdmInMe (www.admin-me.com) - Agile Content (www.agilecontent.com) - eGarante: (www.egarante.com) - Excom (www.excom.es) - Imegen (www.imegen.es) - Indexa Capital (www.indexacapital.com) - Joinup (www.joinuptaxi.com) - Kuaderno (www.kuaderno.com) - Masmovil (www.masmovil.es) - Next (www.gruponext.es) - Nuubo (www.nuubo.com) - Playfilm (www.playfilm.tv) - Quantyca (www.quantyca.com)

Investment focus

Software, Automotive, Telecommunications
Seed, Pre-Seed, Series A
Spain

Portfolio highlights

Lawwwing — Lawwwing provides a distinctive solution in the market for website compliance. It's a platform that automatically adapts your website or online store to regulations, keeping it up-to-date and personalized.
Rauda AI — Rauda is an artificial intelligence platform specialized in automating customer service with the best customer experience. Take a quantum leap in productivity, reduce costs and improve customer satisfaction with the power of generative artificial intelligence.
CHECKTOBUILD — Compare automatically the reality of your construction inspection with the BIM Model and get an accurate as-built analysis.

Ezten Venture Capital Fund

Investment focus

Software, Automotive, Clean Energy
Funding Round, Seed
Spain

Portfolio highlights

EPowerlabs — EPowerlabs offers electric mobility components both in passenger car and heavy duty segments to help OEM and Tier 1 build electric cars
Multiverse Computing — World leaders in quantum computing for the financial industry. The first quantum & quantum-inspired toolbox for finance.
Atlas Molecular Pharma — Latest News Your browser does not support the video tag.

CDTI

Investment focus

Apps, Big Data, Aerospace
Pre-Seed, Series A
Spain

Portfolio highlights

Inspide — Understand all the information in the real world and make it actionable
FYLA — At FYLA we create unique All-fiber Ultrafast pulsed lasers by Joining Singularity with Quality. Discover our multiphoton and two photon lasers!
2Eyes Vision — 2EyesVision is a start-up (CSIC spin-off) specialized in the creation, development, and commercialization of novel ophthalmic technologies.

Learn about the approach the Novartis Venture Fund takes to investing in innovative life science companies developing biotechnology and biopharmaceutical therapeutics that address unmet patient needs.

Investment focus

Biotechnology, Health Care, Therapeutics
Series A, Series B, Series C
United States, Switzerland, United Kingdom

Portfolio highlights

Rhygaze — RhyGaze is at the forefront of developing a novel first-in-class gene therapy aimed at improving vision in patients suffering from retinal diseases.
Granite Bio — Targeting fundamentals of Inflammation, Autoimmunity and Fibrosis. Granite Bio develops first-in-class therapeutic antibodies depleting pathogenic cells with the potential to transform inflammatory and fibrotic diseases.
Atalanta Therapeutics — Atalanta was created to address the urgent global need for interventions to treat neurodegenerative diseases.

Reig Jofre is a manufacturer of pharmaceutical products. The company produces drugs, penicillin antibiotics, and other pharmaceutical products.

Investment focus

Medical, Biopharma, Life Science
Funding Round
Spain

Portfolio highlights

Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer

Originally studying medicine in Scotland, John is a pioneer of the Australasian medical recruitment industry and has over 20 years of experience growing his award-winning business, Wavelength International, from two founders to over 100 staff. Moving to Europe in 2012, John worked initially for an equity crowdfunding business focused on raisingseed funds for European life sciences start-ups, before launching the Luka Global Group, including LUKA BIO, with the co-founders in 2019. John provides guidance and mentorship to start-up founders on how to set up their own in-house recruitment capabilities in preparation for growth. His recruitment portfolio includes C-suite, medical and research roles within life sciences.

Investment focus

FinTech, Medical, Life Science
Debt Financing
Spain

Portfolio highlights

Capital Cell — Capital Cell is a pan-European crowdinvesting platform for Biotech & Life Sciences companies. Mixing VC, business angels, accredited investors and the power of the Crowd, the company is building a global meeting point for companies and researchers working, fostering and financing tomorrow’s medical science.

Inaki Berenguer is the President and Co-founder at iPronics Programmable Photonics.

Investment focus

E-Commerce, FinTech, Software
Seed, Angel, Pre-Seed
Spain, United States, United Kingdom

Portfolio highlights

Goin — Goin is a mobile application to save money easily and take advantage of it without knowing how to invest, through Machine Learning algorithms that allow you to accumulate the user's money through small daily gestures. he three Spanish founders, David, Carlos and Gabriel, were looking for a way to optimize their own money, and decided toconduct an experiment by exchanging their debit cards and thus saving 62% during those two months of rehearsal. This is how Goin emerged, which aims to meet the needs of 100% of Millennials, of which 83% confess that they do not know how to save, making available an easy-to-use tool that enhances their finances and lifestyle. On the one hand, the Barcelona startup allows the user to add money automatically and multiply it without having previous knowledge of investment. Goin uses a simple system that first asks to know the user through questions about their habits and, in this way, they are offered automatic systems and methods of saving. Once the user adds money to the app, they can transfer part or all of it to investment, or to their bank account. Its Smart Saving technology manages to accumulate money with small, everyday gestures, such as rounding a payment.
Bankflip — Permissioned data technology to collect and process your customers' income, tax, employment & other relevant data & documents in real-time
Mable (Neurolytic Healthcare) — Neurolytic Healthcare provides personalized medicine for neurological conditions. Neurolytic Healthcare collects and extracts insights from a combination of genetic and biomarker data to enhance diagnosis and help clinicians decide on optimal treatment strategies for neurological conditions.The company delivers digitally and genomically-drivenmedical devices to improve the current treatment of migraine and other neurological disorders, including a diagnostic support tool, pharmacogenetic test, and a mobile app for migraine event prediction.

We back bold and purpose-driven founders.

Investment focus

Software, Insurance, InsurTech
Series A, Seed, Funding Round
Spain, United States, United Kingdom

Portfolio highlights

LAIIER — The best LAIIER of defense against liquid leak-driven damage in buildings and industrial equipment.
Ole Insurance Group — Ole Insurance Group focuses on offering protection and well-being products and services through technology. Ole Insurance Group was founded in 2021 and was headquartered in Puerto Rico.
Epoch Biodesign — Mellizyme Biotechnology is currently operating in stealth.

David Brandes - Managing Director & Co-Founder @ Peace of Meat

Investment focus

Wellness, Life Science, Biotechnology
Seed
Spain

Portfolio highlights

Libre Foods — Libre Foods is a biotech startup on a mission to liberate the food system and create a more free future for people, the planet, and animals. The company was founded in 2020 and is based in Barcelona, Catalonia, Spain.

stemar capital private equity philippe costeletos

Investment focus

Genetics, Life Science, Biotechnology
Series A
Spain

Portfolio highlights

Veritas Intercontinental — Our test based on whole exome and genome sequencing provides the interpretation of extensive genetic information that can be further analyzed in the future.

We invest in early & growth stage technology companies. We were founded with a mission to support visionaries in building impactful & enduring businesses.

Investment focus

Software, FinTech, Financial Services
Series A, Series B, Series C
United States, Brazil, Canada

Portfolio highlights

Tines — The AI orchestration and automation platform loved by security-minded teams. Operate more effectively, mitigate risk, reduce tech debt, and do the work that matters most.
Base Power — Base provides a battery-powered home energy service so you can enjoy power without interruption and save money. Now available in select regions of Texas.
SuperOps.ai — SuperOps is a future-ready, unified PSA-RMM platform for modern MSPs. Break away from the bane of LegacyOps tools and unlock your full potential.

Life sciences R&D, consulting and investment

Investment focus

Medical, Pharmaceutical, Biopharma
Seed, Pre-Seed, Funding Round
Spain

Portfolio highlights

Thytech — Thytech is a health tech company.
Affirma Biotech — Affirma Biotech develops new orally available immunotherapeutic drugs for the treatment of severe infections and cancer
Ownmed Innovation — Ownmed Innovation is a Medtech spin-off that emerged from the collaboration between the Fundación para la Investigación Biomédica Hospital Gregorio Marañón (FIBHGM), the Instituto Investigación Sanitaria Fundación Jiménez Díaz (IIS-FJD) and Universidad Carlos III de Madrid (UC3M). Its main objective is the development of a medical device, Ostofix®,aimed at ostomate patients, with the purpose of restoring their ability to regain control over their continence.

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Investment focus

Biotechnology, Health Care, Medical
Series A, Series B, Series C
France, United States, United Kingdom

Portfolio highlights

Latent Labs — Latent Labs is making biology programmable to transform health and sustainability for the benefit of all.We are a frontier AI lab building foundational models that capture the fundamentals of biology. We empower partners with breakthrough generative AI to gain unprecedented control over molecular biology, creating new antibodies, optimizingexisting enzymes, and advancing genetic engineering.Contact us to work with us today.
Signadori Bio — Signadori Bio is the next-generation cellular immunotherapy for cancer cure.This has culminated in the creation of a groundbreaking biotech venture in the cell and gene space that is set to advance innovative approaches in oncology.
Forth Therapeutics — Forth Therapeutics is a biotechnology company dedicated to advancing precision treatments for fibrosis.

Investors by industry

Artificial intelligence